Early-life risk factors for chronic nonrespiratory diseases

European Respiratory Journal

Volumn 45, Issue 1, 2015, Pages 244-259

  Chacko, Archana ^a   Carpenter, David O ^b   Callaway, Leonie ^a   Sly, Peter D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC NONRESPIRATORY DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY LIFE ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; EVIDENCE BASED MEDICINE; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DIABETES MELLITUS; HEALTH; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; RESPIRATION DISORDERS;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COGNITION DISORDERS; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; GLOBAL HEALTH; HUMANS; NERVOUS SYSTEM DISEASES; OBESITY; RESPIRATION DISORDERS; RISK FACTORS;

EID: 84920625804     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00070214     Document Type: Article

References (185)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. World Health Organization. Household Air Pollution and Health. www.who.int/mediacentre/factsheets/fs292/en/Last updated: March 2014.
3. Vos T, Flaxman A, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-2196.
4. Murray C, Ezzati M, Flaxman A, et al. GBD 2010: design, definitions, and metrics. Lancet 2012; 380: 2063-2066.
5. Lim S, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for thte Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
6. Sly PD, Neira M, Collman G, et al. Networking to advance progress in children's environmental health. Lancet Glob Health 2014; 2: e129-e130.
7. Balbus J, Barouki R, Birnbaum L, et al. Early-life prevention of non-communicable diseases. Lancet 2013; 381: 3-4.
8. Gluckman P, Hansen M, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359: 61-73.
9. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol 2014; 13: 330-338.
10. Lee D, Steeffes M, Sjodin A, et al. Low dose of some persistent organic pollutants predicts Type 2 diabetes: a nested case-control study. Environ Health Perspect 2010; 118: 1235-1242.
11. Newbold R. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones 2010; 9: 206-217.
12. Slotkin T. Does early-life exposure to organophosphate insecticides lead to prediabetes and obesity? Reproductive Toxicol 2011; 31: 297-301.
13. Sly P. Environmental contributions to chronic non-communicable diseases: redefining environmental diseases. J Environ Immunol Toxicol 2013; 1: 51-52.
14. Symeonides C, Ponsonby A, Vuillermin P, et al. Environmental chemical contributions to ADHD and the externalising disorders of childhood. J Environ Immunol Toxicol 2013; 1: 92-104.
15. Grant K, Carpenter D, Sly J, et al. Environmental contributions to obesity and type 2 diabetes. J Environ Immunol Toxicol 2013; 1: 80-91.
16. Puga A, Maier A, Medvedovic M. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem Pharmacol 2000; 60: 1129-1142.
17. Jirtle RL, Skinner M. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 6: 253-262.
18. Vandenberg L, Chahoud I, Heindel J, et al. Urinary, circulating and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118: 1055-1070.
19. Carraro S, Scheltema N, Bont L, et al. Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing. Eur Respir J 2014; 44: 1682-1696.
20. Newbold R. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones 2010; 9: 206-217.
21. Lee D, Lee I, Song K, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 2006; 29: 1338-1644.
22. Porta M, Lee D. Review of the science linking chemical exposures to the human risk of obesity and diabetes. www.chemtrust.org.uk/wp-content/uploads/CHEM-Trust-Obesity-Diabetes-Full-Report.pdf Date last accessed: August 16, 2014. Date last updated: January 2012.
23. Alonso-Magdalena P, Ropero A, Soriano S, et al. Bisphenol-A: a new diabetogenic factor? Hormones 2010; 9: 118-126.
24. Makaji E, Raha S, Wade M, et al. Effect of environmental contaminants on Beta cell function. Int J Toxicol 2011; 30: 410-418.
25. Lang I, Galloway T, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. J Am Med Assoc 2008; 300: 1303-1310.
26. Alonso-Magdalena P, Vieira E, Soriano S, et al. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 2010; 118: 1243-1250.
27. Ryan K, Haller A, Sorrell J, et al. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010; 151: 2603-2612.
28. Wei J, Lin Y, Li Y, et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 2011; 152: 3049-3061.
29. Cupul-Uicab L, Skjaerven R, Huan K, et al. In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect 2012; 120: 355-360.
30. Karmaus W, Osuch J, Eneli I, et al. Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med 2009; 66: 143-149.
31. Mendez M, Garcia-Esteban R, Guxens M, et al. Prenatal organochlorine compound exposure, rapid weight gain, and overweight in infancy. Environ Health Perspect 2011; 119: 272-278.
32. Smink A, Ribas-Fito N, Garcia R, et al. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatrica 2008; 97: 1465-1469.
33. Valvi D, Mendez M, Martinez D, et al. Prenatal concentrations of poly chlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Eviron Health Perspect 2012; 120: 451-457.
34. Verhulst S, Nelen V, Den Hond E, et al. Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect 2009; 117: 122-126.
35. Dhooge W, Den Hond E, Koppen G, et al. Internal exposure to pollutants and body size in Flemish adolescents and adults: associations and dose-response relationships. Environ Int 2010; 36: 330-337.
36. Kim M, Pelloux V, Guyot E, et al. Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environ Health Perspect 2012; 120: 205-214.
37. Shug T, Janesick A, Blumberg B, et al. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011; 127: 204-215.
38. Lin C, Chen P, Lin Y, et al. Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care 2009; 32: 702-707.
39. Trasande L, Attina T, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. J Am Med Assoc 2012; 308: 1113-1121.
40. Hatch E, Nelson J, Qureshi M, et al. Association of urinary phthalate metabolic concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Eviron Health 2008; 7: 27-41.
41. Padilla M, Elobeid M, Ruden D, et al. An examination of the association of selected toxic metals with total and central obesity indices: NHANES 99-02. Int J Environ Res Public Health 2010; 7: 3332-3347.
42. Harley KG, Aguilar Schall R, Chevrier J, et al. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect 2013; 121;514-20: 20e1-6.
43. Tsai F, Coyle WJ. The microbiome and obesity: is obesity linked to our gut flora? Curr Gastroenterol Rep 2009; 11: 307-313.
44. Gollwitzer ES, Marsland BJ. Microbiota abnormalities in inflammatory airway diseases: potential for therapy. Pharmacol Therapeut 2014; 141: 32-39.
45. van Nimwegen FA, Penders J, Stobberingh EE, et al. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immun 2011; 128: 948-U371.
46. Azad MB, Konya T, Maughan H, et al. Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity. Allergy Asthma Clin Immunol 2013; 9: 15.
47. Bergström A, Skov TH, Bahl MI, et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 2014; 80: 2889-2900.
48. Reinhardt C, Reigstad CS, Backhed F. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastr Nutr 2009; 48: 249-256.
49. Snedeker S, Hay A. Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect 2012; 120: 332-339.
50. Philippat C, Mortamais M, Chevrier C, et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect 2012; 120: 464-470.
51. Chen MH, Ha EH, Wen TW, et al. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 2012; 7: e42474.
52. Darrow LA, Stein CR, Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010. Environ Health Perspect 2013; 121: 1207-1213.
53. Whitworth KW, Haug LS, Baird DD, et al. Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study. Am J Epidemiol 2012; 175: 1209-1216.
54. Snijder CA, Roeleveld N, te Velde E, et al. Occupational exposure to chemicals and fetal growth: the Generation R Study. Hum Reprod 2012; 27: 910-920.
55. Huang Y, Li J, Garcia JM, et al. Phthalate levels in cord blood are associated with preterm delivery and fetal growth parameters in Chinese women. PLoS One 2014; 9: e87430.
56. Meeker JD, Hu H, Cantonwine DE, et al. Urinary phthalate metabolites in relation to preterm birth in Mexico city. Environ Health Perspect 2009; 117: 1587-1592.
57. Callaway LK, Lawlor DA, O'Callaghan M, et al. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol 2007; 197: 492.e1-7.
58. Callaway LK, McIntyre HD, O'Callaghan M, et al. The association of hypertensive disorders of pregnancy with weight gain over the subsequent 21 years: findings from a prospective cohort study. Am J Epidemiol 2007; 166: 421-428.
59. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
60. Robledo C, Peck JD, Stoner JA, et al. Is bisphenol-A exposure during pregnancy associated with blood glucose levels or diagnosis of gestational diabetes? J Toxicol Environ Health A 2013; 76: 865-873.
61. Field A, Coakley E, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-1586.
62. Nguyen Q, Srinivasan S, Xu J, et al. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetics subjects. Diabetes Care 2008; 31: 2044-2049.
63. Zhang Y, Wang S. The relationship of body mass index distribution to relatively high blood pressure among children and adolescents in Shandong, China. Ann Human Bio 2011; 38: 630-634.
64. Reilly J, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obesity 2011; 35: 891-898.
65. Williams D, Going S, Lohman T, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health 1992; 82: 358-363.
66. Mokha J, Srinivasan S, DasMahapatra P, et al Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa heart study. BMC Pediatr 2010:10: 73.
67. Codru N, Schymura M, Negoita S, et al. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007; 115: 1442-1447.
68. Lee D, Lee I, Jin S, et al. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2007; 30: 622-628.
69. Fors E. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005; 115: 897-909.
70. Hallstrand T, Fischer M, Wurfel M, et al. Genetic pleiotropy between asthma and obesity in a community-based sample of twins. J Allergy Clin Immunol 2005; 116: 1235-1241.
71. Howard T, Meyers D, Bleecker E. Mapping susceptibility genes for asthma and allergy. J Allergy Clin Immunol 2000; 105: S477-S481.
72. Tantisira K, Weiss S. Complex interactions in complex traits: obestiy and asthma. Thorax 2001; 56: Suppl. 2, ii64-ii73.
73. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev 2007; 29: 49-61.
74. Aoki T, Hirota T, Tamari M, et al. An association between asthma and TNF-308G/A polymorphism: meta-analysis. J Hum Genet 2006; 51: 677-685.
75. Sookoian S, Gonxalex C, Priola C. Meta-analysis on the G-308A tumour necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005; 13: 2122-2131.
76. Hamid Y, Urhammer S, Glummer C, et al. The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia 2005; 48: 445-451.
77. Randolph A, Lange C, Silverman E, et al. Extended haplotype in the tumor necrosis factor gene cluster is associated with asthma and asthma-related phenotypes. Am J Respir Crit Care Med 2005; 172: 687-692.
78. Want T, Chen W, Want T, et al. Gene-gene synergistic effect on atopic asthma: tumour necrosis factor-α-308 and lyphotoxin-α-NcoI in Taiwan's children. Clin Exp Allergy 2004; 34: 184-188.
79. Poon A, Laprise C, Lemire M, et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med 2004; 170: 967-973.
80. Raby B, Lazarus R, Silverman E, et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med 2004; 170: 1057-1065.
81. Wjst M, Altmuller J, Faus-Kessler T, et al. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res 2006; 7: 60.
82. McCarthy A, Hughes R, Tilling K, et al. Birth weight; postnatal, infant and childhood growth; and obesity in young adulthood: evidence from the Barry Caerphilly Growth Study. Am J Clin Nutr 2007; 86: 907-913.
83. Sachdev H, Fall C, Osmond C, et al. Anthropometric indicators of body composition in young adults: relation to size at birth and serial measurements of body mass index in the New Delhi birth cohort. Am J Clin Nutr 2005; 82: 456-466.
84. Galan P, Viteri F, Bertrais S, et al. Serum concentrations of beta-carotene, vitamin C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 2005; 59: 1181-1190.
85. Kimmons J, Blanck H, Tohill B, et al. Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med 2006; 8: 59.
86. Parikh S, Edelman M, Uwaifo G, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-1199.
87. Snijder M, van Dam R, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119-4123.
88. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immun 2011; 128: 646-652.
89. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
90. Larsen N, Vogensen F, van den Berg F, et al. Gut microbiota in humn adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: e9085.
91. Guerra S, Sherrill D, Bobadilla A, et al. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002; 122: 1256-1263.
92. Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253: 574-581.
93. Lazarus R, Sparrow D, Weiss S. Impaired ventilatory function and elevated insulin levels in nondiabetic males: the Normative Aging Study. Eur Respir J 1998; 12: 635-640.
94. Lee E, In K, Ha E, et al. Asthma-like symptoms are increased in the metabolic syndrome. J Asthma 2009; 46: 339-342.
95. McKeever T, Weston P, Hubbard R, et al. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005; 161: 546-556.
96. de Lucas-Ramos P, Izquierdo-Alonso J, Rodríguez-González Moro J, et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study. Arch Bronconeumol 2008; 44: 233-238.
97. Mannino D, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969.
98. Barnes P, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
99. Bruin J, Kellenberger L, Gerstein H, et al. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure. J Endocrinol 2007; 194: 171-178.
100. Montgomery S, Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ 2002; 324: 26-27.
101. Entringer S, Wüst S, Kumsta R, et al. Prenatal psychosocial stress exposure is associated with insulin resistance in young adults. Am J Obstet Gynecol 2008; 199: e1-7.
102. Li J, Olsen J, Vestergaard M, et al. Prenatal exposure to bereavement and type-2 diabetes: a Danish longitudinal population based study. PLoS One 2012:7e43508.
103. Maty S, Lynch J, Raghunathan T, et al. Childhood socioeconomic position, gender, adult body mass index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda County Study. Am J Public Health 2008; 98: 1486-1494.
104. Tamayo T, Christian H, Rathmann W. Impact of early psychosocial factors (childhood socioeconomic factors and adversities) on future risk of type 2 diabetes, metabolic disturbances and obesity: a systematic review. BMC Public Health 2010; 10: 525.
105. Rajagopalan S, Brook R. Air pollution and type 2 diabetes: mechanistic insights. Diabetes 2012; 61: 3037-3045.
106. O'Toole T, Conklin D, Bhatnagan A. Environmental risks for heart disease. Rev Environ Health 2008; 23: 167-202.
107. La Merrill M, Cirillo P, Terry M, et al. Prenatal exposure to the pesticide DDT and hypertension diagnosed in women before age 50: a longitudinal birth cohort study. Environ Health Perspect 2013; 121: 594-599.
108. Gall S, Huynh Q, Magnussen C, et al. Exposure to parental smoking in childhood or adolescence is associated with increased carotid intima-media thickness in young adults: evidence from the Cardiovascular Risk in Young Finns and the Childhood Determinants of Adult Health Study. Eur Heart J 2014; 35: 2484-2491.
109. Sun C, Burgner D, Ponsonby A, et al. Effects of early-life environmental and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies. Pediatr Res 2013; 73: 523-530.
110. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
111. McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415.
112. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11.
113. Macchia A, Monte S, Romero M, et al. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 2007; 9: 942-948.
114. Anthonisen NR, Connett JE, Enright PL, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
115. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
116. Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994; 154: 1277-1282.
117. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 1998; 97: 2012-2016.
118. Kallio K, Jokinen E, Hamalainen M, et al. Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke. Pediatrics 2009; 123: e267-73.
119. Kallio K, Jokinen E, Raitakari OT, et al. Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 2007; 115: 3205-3212.
120. Leeson CP, Whincup PH, Cook DG, et al. Flow-mediated dilation in 9-to 11-year-old children: the influence of intrauterine and childhood factors. Circulation 1997; 96: 2233-2238.
121. Al Mamun A, Lawlor D, Alati R, et al. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol 2006; 164: 317-325.
122. Oken E, Levitan E, Gillman M. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes 2008; 32: 201-210.
123. Power C, Atherton K, Thomas C. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis 2010; 211: 643-648.
124. Toschke A, Koletzko B, Slikker WJ, et al. Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr 2002; 161: 445-448.
125. Morley R, Leeson Payne C, Lister G, et al. Maternal smoking and blood pressure in 7.5 to 8 year old offspring. Arch Dis Child 1995; 72: 120-124.
126. Jaddoe V, de Ridder M, van den Elzen A, et al. Maternal smoking in pregnancy is associated with cholesterol development in the offspring: a 27-years follow-up study. Atherosclerosis 2008; 196: 42-48.
127. Bruce K, Hanson M. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010; 140: 648-652.
128. Fernandez-Twinn D, Ozanne S. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006; 88: 234-243.
129. Huxley R, Owen C, Whincup P, et al. Birth weight and subsequent cholesterol levels: exploration of the "fetal origins" hypothesis. J Am Med Assoc 2004; 292: 2755-2764.
130. Peters A, Liu E, Verrier RL, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiol 2000; 11: 11-17.
131. Poloniecki JD, Atkinson RW, de Leon AP, et al. Daily time series for cardiovascular hospital admissions and previous day's air pollution in London, UK. Occup Environ Med 1997; 54: 535-540.
132. Dominici F, McDermott A, Daniels M, et al. Mortality Among Residents of 90 Cities. Boston, Health Effects Institute, 2003.
133. Pope CA, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term exposure to particulate air pollution -epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109: 71-77.
134. Samet JM, Dominici F, Curriero FC, et al. Fine particulate air pollution and mortality in 20 US Cities, 1987-1994. N Engl J Med 2000; 343: 1742-1749.
135. Suwa T, Hogg JC, Quinlan KB, et al. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002; 39: 935-942.
136. Peters A, Döring A, Wichmann H, et al. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997; 49: 1582-1587.
137. Seaton A, Soutar A, Crawford V, et al. Particulate air pollution and the blood. Thorax 1999; 54: 1027-1032.
138. Donaldson K, Stone V, Seaton A, et al. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 2001; 109: 523-527.
139. Pekkanen J, Peters A, Hoek G, et al. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease -the exposure and risk assessment for fine and ultrafine particles in ambient air (ULTRA) study. Circulation 2002; 106: 933-938.
140. Peters A, Dockery DW, Muller JE, et al. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001; 103: 2810-2815.
141. Abilleira S, Bevan S, Markus H. The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet 2006; 43: 897-901.
142. Churg A, Zhou S, Wright J. Matrix metalloproteinases in COPD. Eur Respir J 2012; 39: 197-209.
143. Wang J, Xu D, Wu X, et al. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 2011; 97: 1542-1546.
144. Singh N, Sinha N, Kumar S, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor for acute myocardial infarction and smoking in the North Indian population. Cardiol 2011; 118: 16-21.
145. Wang Y, Ulu A, Zhang L, et al. Soluble epoxide hydrolase in atherosclerosis. Curr Atheroscler Rep 2010; 12: 174-183.
146. Iribarren C, Tolstykh IV, Miller MK, et al. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol 2012; 176: 1014-1024.
147. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2007; 195: 129-137.
148. Schanen JG, Iribarren C, Shahar E, et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005; 60: 633-638.
149. Zureik M, Kony S, Neukirch C, et al. Bronchial hyperresponsiveness to methacholine is associated with increased common carotid intima-media thickness in men. Arterioscl Throm Vas 2004; 24: 1098-1103.
150. Landrigan P, Lambertini L, Birnbaum L. A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Environ Health Perspect 2012; 120: A258-A260.
151. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2197-2223.
152. Aguiar A, Eubig PA, Schantz SL. Attention deficit/hyperactivity disorder: a focused overview for children's environmental health researchers. Environ Health Perspect 2010; 118: 1646-1653.
153. Polanczyk G, Silva de Lima M, Horta B, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942-948.
154. Bellinger D. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 2012; 120: 501-507.
155. Eubig P, Aguiar A, Schantz S. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 2010; 118: 1654-1667.
156. Yolton K, Dietrich K, Auinger P, et al. Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environ Health Perspect 2005; 113: 98-103.
157. Smith A, Mick E, Faraone S. Advances in genetic studies of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2009; 11: 143-148.
158. Pennington B, McGrath L, Rosenberg J, et al. Gene × environment interactions in reading disability and attention-deficit/hyperactivity disorder. Dev Psychol 2009; 45: 77-89.
159. Lawlor D, Majman J, Batty G, et al. Early life predictors of childhood intelligence: findings from the Mater-University Study of Pregnancy and its outcomes. Paediatr Perinat Epidemiol 2006; 20: 148-162.
160. Sorensen H, Sabroe S, Olsen J, et al. Birth weight and cognitive function in young adult life: historical cohort study. BMJ 1997; 315: 410-413.
161. StSauver J, Barbaresi W, Katusic S, et al Early life risk factors for attention-deficit/hyperactivity disorder: a population-based cohort study. Mayo Clin Proc 2004; 79: 1124-1131.
162. Biederman J. Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Arch Gen Psychiatr 1995; 52: 464-470.
163. Robinson M, Mattes E, Oddy W, et al. Prenatal stress and risk of behavioral morbidity from age 2 to 14 years: the influence of the number, type and timing of stressful life events. Dev Psychpathol 2011; 23: 507-520.
164. Robinson M, Oddy W, Li J, et al. Pre-and postnatal influences on preschool mental health: a large-scale cohort study. Child Psychol Psychiatr 2008; 49: 1118-1128.
165. Ronald A, Pennell C, Whitehouse A. Prenatal maternal stress associated with ADHD and autistic traits in early childhood. Front Psychol 2011; 1: 1-8.
166. Robinson M, Oddy W, McLean N, et al. Low-moderate prenatal alcohol exposure and risk to child behavioural development: a prospective cohort study. BJOG 2010; 117: 1139-1152.
167. Kalbrenner A, Braun J, Durkin M, et al. Maternal smoking during pregnancy and the prevalence of autism spectrum disorders, using data from the autism and developmental disabilities monitoring network. Environ Health Perspect 2012; 120: 1042-1048.
168. Mick E, Biederman J, Faraone S, et al. Case-control study of attention deficit hyperactivity disorder and maternal smoking, alcohol use and drug use during pregnancy. J Am Acad Child Adol Psychiatr 2002; 41: 378-385.
169. Oddy W, Kendall G, Li J, et al. The long-term effects of breastfeeding on child and adolescent mental health: a pregnancy cohort study followed for 14 years. J Pediatr 2010; 156: 568-574.
170. Whitehouse A, Holt B, Serralha M, et al. Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatr 2012; 129: 485-493.
171. Blackman J, Gurka M. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 2007; 28: 92-99.
172. Chen M, Su T, Chen Y, et al. Asthma and attention-deficit/hyperactivity disorder: a nationwide population-based prospective cohort study. J Child Psychol Psychiatr 2013; 54: 1208-1214.
173. Mogensen N, Larsson H, Lundholm C, et al. Association between childhood asthma and ADHD symptoms in adolescence-A prospective population-based twin study. Allergy 2011; 66: 1224-1230.
174. Drtilkova I, Sery O, Theiner P, et al. Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett 2008; 29: 320-327.
175. Oades RD, Dauvermann MR, Schimmelmann BG, et al. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism -effects of medication. Behav Brain Funct 2010; 6: 29.
176. Eskenazi B, Castorina R. Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 1999; 107: 991-1000.
177. Thomas JD, Garrison ME, Slawecki CJ, et al. Nicotine exposure during the neonatal brain growth spurt produces hyperactivity in preweanling rats. Neurotoxicol Teratol 2000; 22: 695-701.
178. Ronald A, Pennell CE, Whitehouse AJ. Prenatal maternal stress associated with ADHD and autistic traits in early childhood. Front Psychol 2010; 1: 223.
179. Beydoun H, Saftlas AF. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol 2008; 22: 438-466.
180. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010; 24: 881-897.
181. Adams J, Jahansen L, Powell L, et al. Gastrointestinal flora and gastrointestinal status in children with autism -comparisons to typical children and correlation with autism severity. Gastroenterol 2011; 11: 22.
182. Kang DW, Park J, Ihran Z, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 2013; 8: e68322.
183. Parracho H, Bingham M, Gibson G, et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005; 54: 987-991.
184. Hsiao E, McBride S, Hsien S, et al. Micobiota modulate behavioural and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451-1463.
185. Gondalia S, Palombo E, Knowles S, et al. Molecular characterization of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res 2012; 5: 419-427.